AA
ZBH icon

Apriem Advisors’s Zimmer Biomet ZBH Stock Holding History

Apriem Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-44
Closed -$5K – 567
2017
Q1 		$5K Hold
44
– – ﹤0.01% 489
2016
Q4 		$4K Buy
+44
New +$4.72K ﹤0.01% 552
2016
Q3 		– Sell
-21
Closed -$2K – 651
2016
Q2 		$2K Buy
+21
New +$2.38K ﹤0.01% 543

Other funds holding ZBH

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Apriem Advisors's ZBH Position: Q2 2017 in Review

Apriem Advisors sold out of Zimmer Biomet (ZBH) in Q2 2017, closing a stake of 44 shares — an estimated $5K sold.

Apriem Advisors first reported a position in ZBH in Q2 2016 and held it in 3 quarters. The position peaked at $5K in Q1 2017. 819 funds tracked by Wall St. Rank hold ZBH as of Q2 2017.

  • Apriem Advisors reported no remaining Zimmer Biomet position as of Q2 2017 after selling out during the quarter.
  • Apriem Advisors sold 44 Zimmer Biomet shares in Q2 2017, an estimated $5K.
  • Apriem Advisors first reported a position in Zimmer Biomet in Q2 2016 and held it in 3 quarters.
  • Apriem Advisors's Zimmer Biomet position peaked at $5K in Q1 2017.
  • 819 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2017.

Based on Apriem Advisors's 13F filing for Q2 2017, filed 4 Aug 2017.